# OnCo record tebentafusp (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/tebentafusp/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "tebentafusp" ;
  schema:name "Tebentafusp"@en ;
  schema:description "The first drug to improve survival in metastatic uveal melanoma, and the first TCR-based bispecific."@en ;
  schema:url <https://onco.cc/drugs/tebentafusp/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Tebentafusp> ;
  owl:sameAs <http://www.wikidata.org/entity/Q110757700> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tebentafusp> ;
  onco:status "approved" ;
  onco:modality "ImmTAC (TCR×CD3 bispecific)" ;
  schema:alternateName "Kimmtrak" ;
  onco:approval "US 2022: HLA-A*02:01+ metastatic uveal melanoma" ;
  onco:related <https://onco.cc/biomarkers/hla-a-02-01/> ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/>, <https://onco.cc/technologies/tcr-t/> ;
  onco:targets <https://onco.cc/targets/gp100/>, <https://onco.cc/targets/cd3/>, <https://onco.cc/targets/hla-a/> ;
  onco:companies <https://onco.cc/companies/immunocore/> ;
  onco:terms <https://onco.cc/terms/step-up-dosing/> ;
  onco:trials <https://onco.cc/trials/nct05549297/>, <https://onco.cc/trials/nct04262466/> .